Baxter buys Degussa's Asta Medica Oncology for $463.2mm
Executive Summary
Furthering its move into the oncology pharmaceuticals arena, Baxter Healthcare SA, a Swiss subsidiary of Baxter International Inc. acquired Degussa's oncology division Asta Medica Onkologie (cancer therapeutics) for $463.2mm (Euro525mm) in cash. It expects the transaction to close by year-end.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice